Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mesut Yilmaz

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Journal of Cancer Research and Therapeutics|December 21, 2020
Evaluation of sleep disorders in nonmetastatic breast cancer patients based on pittsburgh sleep quality indexMesut Yilmaz
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 9, 2019
Nivolumab-induced type 1 diabetes mellitus as an immune-related adverse eventMesut Yilmaz
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 18, 2020
Atypical response patterns in metastatic melanoma and renal cell carcinoma patients treated with nivolumab: A single center experienceMesut Yilmaz
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 12, 2021
Two different immune related adverse events occured at pancreas after nivolumab in an advanced RCC patientMesut Yilmaz, Ahmet Baran
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 10, 2019
Hyperprogression after nivolumab for melanoma: A case reportMesut Yilmaz, Burak Akovali
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 20, 2019
Durable response after discontinuation of nivolumab therapy in the absence of disease progression or toxicity with two advanced NSCLC patientsMesut Yilmaz, Sermin Guven Mese
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 1, 2020
Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAF<sup>V600E</sup>-mutant metastatic melanomaMesut Yilmaz, Şermin Güven Meşe
Case Reports in Infectious Diseases|November 6, 2014
Community Acquired Chronic Arthritis due to Pseudomonas aeruginosa in a Previously Healthy Pregnant WomanMesut Yilmaz, Ferhat Arslan, Ali Mert
World Journal of Clinical Cases|February 29, 2020
Radiation recall dermatitis with dabrafenib and trametinib: A case reportMesut Yilmaz, Ugur Celik, Seyhan Hascicek
Journal of Neurosurgery. Spine|January 2, 2010
"Skip" corpectomy in the treatment of multilevel cervical spondylotic myelopathy and ossified posterior longitudinal ligamentSedat Dalbayrak, Mesut Yilmaz, Sait Naderi
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Journal of Cancer Research and Therapeutics|December 21, 2020
Evaluation of sleep disorders in nonmetastatic breast cancer patients based on pittsburgh sleep quality indexMesut Yilmaz
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 9, 2019
Nivolumab-induced type 1 diabetes mellitus as an immune-related adverse eventMesut Yilmaz
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 18, 2020
Atypical response patterns in metastatic melanoma and renal cell carcinoma patients treated with nivolumab: A single center experienceMesut Yilmaz
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 12, 2021
Two different immune related adverse events occured at pancreas after nivolumab in an advanced RCC patientMesut Yilmaz, Ahmet Baran
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 10, 2019
Hyperprogression after nivolumab for melanoma: A case reportMesut Yilmaz, Burak Akovali
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 20, 2019
Durable response after discontinuation of nivolumab therapy in the absence of disease progression or toxicity with two advanced NSCLC patientsMesut Yilmaz, Sermin Guven Mese
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 1, 2020
Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAF<sup>V600E</sup>-mutant metastatic melanomaMesut Yilmaz, Şermin Güven Meşe
Case Reports in Infectious Diseases|November 6, 2014
Community Acquired Chronic Arthritis due to Pseudomonas aeruginosa in a Previously Healthy Pregnant WomanMesut Yilmaz, Ferhat Arslan, Ali Mert
World Journal of Clinical Cases|February 29, 2020
Radiation recall dermatitis with dabrafenib and trametinib: A case reportMesut Yilmaz, Ugur Celik, Seyhan Hascicek
Journal of Neurosurgery. Spine|January 2, 2010
"Skip" corpectomy in the treatment of multilevel cervical spondylotic myelopathy and ossified posterior longitudinal ligamentSedat Dalbayrak, Mesut Yilmaz, Sait Naderi
Pageof 12